Location History:
- Chapel Hill, NC (US) (2017 - 2019)
- Durham, NC (US) (2021 - 2022)
Company Filing History:
4 out of 2,009 
1 out of 1,271 
Years Active: 2017-2022
Title: Kouros Owzar: Innovator in Cancer Treatment
Introduction
Kouros Owzar is a prominent inventor based in Durham, NC (US), known for his significant contributions to cancer research and treatment. He holds 4 patents that focus on innovative methods for predicting and treating cancer. His work has the potential to greatly enhance the effectiveness of cancer therapies.
Latest Patents
Owzar's latest patents include groundbreaking methods for predicting the responsiveness of cancer to VEGF targeting agents. These methods involve obtaining a sample from a subject, determining the expression level of biomarkers such as VEGF-D and PlGF, and comparing these levels to reference standards. This process allows for the prediction of how well a cancer will respond to specific treatments. Additionally, he has developed methods for identifying the risk of vascular endothelial growth factor (VEGF) pathway inhibitor-induced hypertension, which involves measuring gene mutations in patient samples.
Career Highlights
Throughout his career, Kouros Owzar has worked with esteemed institutions such as Duke University and the University of North Carolina at Chapel Hill. His research has focused on improving cancer treatment outcomes and understanding the complexities of cancer therapies.
Collaborations
Owzar has collaborated with notable colleagues, including Sharareh Reihani and Mark W Dewhirst. These partnerships have contributed to the advancement of his research and the development of innovative cancer treatment methods.
Conclusion
Kouros Owzar's work in cancer research exemplifies the impact of innovation in medical science. His patents and collaborations highlight his commitment to improving cancer treatment and patient outcomes.